65,437 trials
Acute Respiratory Distress Syndrome · COVID-19 Pneumonia
Primary: Change in the PaO2/FiO2* Ratio From Baseline to Day 7 of Treatment Administration — 83.3; 57.6 mmHg/mmHg
Dry Eye Disease
Primary: Percentage of Subjects With Ocular Treatment-Emergent Adverse Events Attributed to Study Intervention — 0; 3.6 percentage of subjects
Presbyopia Condition
Primary: The Primary Effectiveness Endpoint for the Study is Monocular (Study [Right] Eye Only) Photopic Negative Lens-induced Distance-corrected Depth of Focus (DOF) at the 0.2…
Diabetes · Elevated Body Mass Index
Primary: Hemoglobin A1c (HbA1c) Level — 8.40; 8.80; 7.60; 8.25 mmol/mol
Respiratory Syncytial Virus Infections
Primary: Number of Maternal Participants With Pregnancy Outcomes From Conception Until Day 42 Post-delivery of the First Pregnancy Conceived Within 2 Years Post-vaccination…
Self-Injurious Behavior · Deliberate Self-Harm
Primary: Self-Injurious Thoughts and Behaviors Interview (SITBI) - Lifetime Episodes — 73.29; 0 episode count
Generalized Pustular Psoriasis
Primary: Percentage of Patients Achieving a GPPPGA Score of 0 (Clear) or 1 (Almost Clear) — 8; 8; 2 Participants
Mobile Phone Use · Hiv · Stigma, Social
Primary: Retention Rate — 20; 24 Participants
Healthy
Primary: Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Basal Oxygen Consumption (OCR) — 18.74; 19.54 pmol/min
Transcatheter Aortic Valve Replacement · Closure Technique
Primary: Number of Participants With Main Access-related Bleeding and Vascular Complications — 47; 42 Participants
Parkinson Disease
Primary: Functional Ambulation Profile (FAP) Score — 99.2; 86.8 FAP score on a scale
Breast Cancer Female
Primary: Measure Ki67 Index in Highly Hormone-dependent Breast Cancers vs. Those That Are Not — 7; 6; 40 Participants
Cancer in Adolescence
Primary: Number of Participants Who Completed the Intervention — 21 Participants
Melanoma · Melanoma, Skin
Primary: Area Under the ROC Curve (AUC) for Melanoma Detection — 0.8482 Probability area (value from 0 to 1)
Hearing Loss · Language Impairment
Primary: Labeling - Acquisition Effectiveness — 3; 3; 3; 3 Participants